PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Consumables – Market size and forecast 2018-2023
• Systems – Market size and forecast 2018-2023
Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• ROW – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• North America – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Strategic alliances
• Presence of government funding and investments
• Growing demand towards non-invasive products
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• bioMérieux
• Bio-Rad Laboratories
• QIAGEN
• Sight Diagnostics
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global point of care (POC) diagnostics market
Exhibit 02: Segments of global point of care (POC) diagnostics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Product – Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Consumables – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Consumables – Year-over-year growth 2019-2023 (%)
Exhibit 21: Systems – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Systems – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 29: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 31: Confirmed cases of malaria in few European countries 2011-2015
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: North America – Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Incidence per 1,000 people in countries 2015
Exhibit 39: Product launches
Exhibit 40: Product recalls
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Strategic business alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Strategies of companies leading to market penetration
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Abbott – Vendor overview
Exhibit 50: Abbott – Business segments
Exhibit 51: Abbott – Organizational developments
Exhibit 52: Abbott – Geographic focus
Exhibit 53: Abbott – Segment focus
Exhibit 54: Abbott – Key offerings
Exhibit 55: Abbott – Key customers
Exhibit 56: bioMérieux – Vendor overview
Exhibit 57: bioMérieux – Business segments
Exhibit 58: bioMérieux – Organizational developments
Exhibit 59: bioMérieux – Geographic focus
Exhibit 60: bioMérieux – Segment focus
Exhibit 61: bioMérieux – Key offerings
Exhibit 62: bioMérieux – Key customers
Exhibit 63: Bio-Rad Laboratories – Vendor overview
Exhibit 64: Bio-Rad Laboratories – Business segments
Exhibit 65: Bio-Rad Laboratories – Organizational developments
Exhibit 66: Bio-Rad Laboratories – Geographic focus
Exhibit 67: Bio-Rad Laboratories – Segment focus
Exhibit 68: Bio-Rad Laboratories – Key offerings
Exhibit 69: Bio-Rad Laboratories – Key customers
Exhibit 70: QIAGEN – Vendor overview
Exhibit 71: QIAGEN – Product segments
Exhibit 72: QIAGEN – Geographic focus
Exhibit 73: QIAGEN – Segment focus
Exhibit 74: QIAGEN – Key offerings
Exhibit 75: QIAGEN – Key customers
Exhibit 76: Sight Diagnostics – Vendor overview
Exhibit 77: Sight Diagnostics – Organizational developments
Exhibit 78: Sight Diagnostics – Key offerings
Exhibit 79: Sight Diagnostics – Key customers
Exhibit 80: Validation techniques employed for market sizing
【掲載企業】
Abbott、bioMérieux、Bio-Rad Laboratories、QIAGEN、Sight Diagnostics
【免責事項】
https://www.marketreport.jp/reports-disclaimer